SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-043484
Filing Date
2023-08-18
Accepted
2023-08-18 16:31:52
Documents
72
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pkbo-20230630.htm   iXBRL 10-Q 2506679
2 EX-31.1 pkbo-ex31_1.htm EX-31.1 20383
3 EX-31.2 pkbo-ex31_2.htm EX-31.2 21360
4 EX-32.1 pkbo-ex32_1.htm EX-32.1 9113
5 EX-32.2 pkbo-ex32_2.htm EX-32.2 9082
  Complete submission text file 0000950170-23-043484.txt   10224319

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pkbo-20230630_def.xml EX-101.DEF 278940
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pkbo-20230630_cal.xml EX-101.CAL 47606
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pkbo-20230630_lab.xml EX-101.LAB 500757
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pkbo-20230630_pre.xml EX-101.PRE 401841
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pkbo-20230630.xsd EX-101.SCH 64719
66 EXTRACTED XBRL INSTANCE DOCUMENT pkbo-20230630_htm.xml XML 1965576
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39951 | Film No.: 231186253
SIC: 2836 Biological Products, (No Diagnostic Substances)